Taking TRUTAKNA
Once-weekly, at-home dosing with TRUTAKNA
Take control of your IgA nephropathy (IgAN) treatment
TRUTAKNA is intended for continuous use and was studied in people taking supportive care treatments.*
Not actual size.
At home
Once weekly
Via autoinjector
It could fit right into my schedule and routine.”
—Anna, living with IgAN
Define:
*Supportive care treatments included RASi (including ACE inhibitors and ARBs) with or without SGLT2i therapies.
ACE=angiotensin-converting enzyme; ARBs=angiotensin receptor blockers; IgA=immunoglobulin A; RASi=renin-angiotensin system inhibitor; SGLT2i=sodium-glucose cotransporter-2 inhibitor.
Make TRUTAKNA part of your weekly routine
Choose a consistent day and time for your injection that is convenient for you. You can think of it as a quick moment to take care of yourself in your busy week
A weekly phone or calendar reminder can help keep your routine on track
The TRUTAKNA autoinjector is designed for ease of use
Ready to use: Each autoinjector is pre-filled, single-use, and disposable
Never see a needle: The needle stays hidden behind the needle shield before, during, and after the injection
Follow the blue: The viewing window fills up with blue to let you know the injection is finished
Getting started with TRUTAKNA
Watch a demonstration of how to use the TRUTAKNA autoinjector.
Please download and read the full Instructions for Use before you use TRUTAKNA and each time you refill your prescription, as there may be new information.
Common questions about using TRUTAKNA
How should I store TRUTAKNA?
TRUTAKNA should stay in its original carton in a safe space in your refrigerator between 36 °F and 46 °F (2 °C and 8 °C)
A TRUTAKNA autoinjector may be kept at room temperature between 60 °F and 77 °F (15 °C and 25 °C) for a single period of up to 3 days (72 hours)
Once TRUTAKNA has been stored at room temperature, it should not be placed back into the refrigerator. Throw away the TRUTAKNA autoinjector if it's not used within these 3 days
Never freeze or shake the autoinjector, and protect it from light. Keep it away from heat and out of reach of children or pets. Safely throw it away if it has expired or is no longer needed
What do I do if I miss a dose?
If you miss a dose of TRUTAKNA on your planned day, inject a dose as soon as possible. Then continue once-weekly dosing based on the new day injected. If you aren't sure when to inject TRUTAKNA, call your healthcare provider.
What do I do if I’m traveling with TRUTAKNA?
Continue to keep the autoinjector between 36 °F and 46 °F (2 °C and 8 °C), away from light, and safely secured. Do not freeze or shake the autoinjector.
Medications may require additional security screening. Visit www.tsa.gov/travel/tsa-cares for the latest requirements.
See what to expect from TRUTAKNA
Download the Consideration Brochure to learn how TRUTAKNA works, see results from a clinical study, and explore financial support
Tru Support for people taking TRUTAKNA
Get access to support, educational resources, and financial assistance through our dedicated support program
INDICATION AND IMPORTANT SAFETY INFORMATION
What is TRUTAKNA?
TRUTAKNA (atacicept-vymj) is a prescription medicine used to reduce levels of protein in the urine (proteinuria) in adults with a kidney disease called primary immunoglobulin A nephropathy (IgAN), who are at risk of their disease getting worse.
It is not known if TRUTAKNA is safe and effective in children.
TRUTAKNA is approved based on reduction of proteinuria. Continued approval may depend on results from an ongoing study to determine whether TRUTAKNA slows decline in kidney function.
IMPORTANT SAFETY INFORMATION
Who should not take TRUTAKNA?
Do not take TRUTAKNA if you are allergic to atacicept-vymj or any of the ingredients in TRUTAKNA. Get emergency help if you develop signs and symptoms of an allergic reaction, including:
breathing problems
swelling of the face, eyes, lips, tongue, or throat
dizziness or lightheadedness
itching
hives
skin rash
Before using TRUTAKNA, tell your doctor about all your medical conditions, including if you:
have or think you have an infection or have infections that keep coming back.
have recently received or are scheduled to receive an immunization (vaccine). TRUTAKNA may affect your immune system response to vaccines and increase your risk of an infection from live vaccines.
You should be brought up to date with all vaccines before starting treatment with TRUTAKNA.
You should not receive live vaccines within 30 days before starting or during treatment with TRUTAKNA.
are pregnant or plan to become pregnant. It is not known if TRUTAKNA will harm your unborn baby. If you become pregnant during treatment with TRUTAKNA, you and your healthcare provider should call 1-833-633-8372.
are breastfeeding or plan to breastfeed. It is not known if TRUTAKNA passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby if you take TRUTAKNA.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using TRUTAKNA with certain medicines may increase your risk of infections.
What are the possible side effects of TRUTAKNA?
TRUTAKNA can cause serious side effects, including:
Immunosuppression and increased risk of infections: TRUTAKNA weakens your immune system, which may increase your risk of infections. Your healthcare provider will check you for signs and symptoms of infections before you start and during treatment with TRUTAKNA. Tell your healthcare provider right away if you develop any signs or symptoms of infection, including:
fever
chills
feeling tired
cough
flu-like symptoms
aches and pains
warm, red, or painful skin
The most common side effects of TRUTAKNA include: upper respiratory tract infection and injection site reactions, such as redness, swelling, itching or skin irritation at the injection site. Your healthcare provider may interrupt treatment with TRUTAKNA if you have serious side effects.
These are not all the possible side effects of TRUTAKNA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Vera Therapeutics at 1-833-MED-VERA or medinfo@veratx.com.
Please see Full Prescribing Information, including Patient Information.
